Posted 2/16/2024, 7:50:00 AM
Mycoplasma Testing Market to Reach $1.9 Billion by 2031 Amid Rising Contamination Concerns and Biopharma Regulations
- Mycoplasma Testing Market projected to reach $1,907.6 million by 2031, growing at a 9.7% CAGR from 2024-2031
- Rising incidences of contamination in cell cultures driving demand for mycoplasma testing
- Stringent regulations mandating testing in biopharma industry increasing adoption
- Preference for PCR-based testing methods and in-house test kits shaping market trends
- North America expected to dominate market due to major pharma companies and research activities